Financial results - DR. NEMER KAMAL - CHIRURGIE ESTETICA S.R.L.

Financial Summary - Dr. Nemer Kamal - Chirurgie Estetica S.r.l.
Unique identification code: 41411593
Registration number: J40/9437/2019
Nace: 8622
Sales - Ron
57.854
Net Profit - Ron
23.872
Employee
1
The most important financial indicators for the company Dr. Nemer Kamal - Chirurgie Estetica S.r.l. - Unique Identification Number 41411593: sales in 2023 was 57.854 euro, registering a net profit of 23.872 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Dr. Nemer Kamal - Chirurgie Estetica S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - 61.030 61.346 59.655 58.202 57.854
Total Income - EUR - - - - - 61.030 61.347 59.655 58.202 57.854
Total Expenses - EUR - - - - - 20.518 19.129 25.039 31.309 33.404
Gross Profit/Loss - EUR - - - - - 40.512 42.218 34.617 26.893 24.450
Net Profit/Loss - EUR - - - - - 38.682 40.555 34.032 26.322 23.872
Employees - - - - - 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -0.3%, from 58.202 euro in the year 2022, to 57.854 euro in 2023. The Net Profit decreased by -2.371 euro, from 26.322 euro in 2022, to 23.872 in the last year.

Check the financial reports for the company - Dr. Nemer Kamal - Chirurgie Estetica S.r.l.

Rating financiar

Financial Rating -
Dr. Nemer Kamal - Chirurgie Estetica...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Dr. Nemer Kamal - Chirurgie Estetica...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dr. Nemer Kamal - Chirurgie Estetica...

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Dr. Nemer Kamal - Chirurgie Estetica...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dr. Nemer Kamal - Chirurgie Estetica S.r.l. - CUI 41411593

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - - 0 1.187 89 0 0
Current Assets - - - - - 40.770 59.087 35.331 27.702 28.447
Inventories - - - - - 8 0 0 0 0
Receivables - - - - - 11.625 0 6.169 26.365 24.842
Cash - - - - - 29.138 59.087 29.162 1.337 3.605
Shareholders Funds - - - - - 38.892 60.124 34.274 26.566 24.114
Social Capital - - - - - 211 207 202 203 202
Debts - - - - - 1.932 149 1.146 1.136 4.338
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 28.447 euro in 2023 which includes Inventories of 0 euro, Receivables of 24.842 euro and cash availability of 3.605 euro.
The company's Equity was valued at 24.114 euro, while total Liabilities amounted to 4.338 euro. Equity decreased by -2.371 euro, from 26.566 euro in 2022, to 24.114 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Dr. Nemer Kamal - Chirurgie Estetica S.r.l.

Comments - Dr. Nemer Kamal - Chirurgie Estetica S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.